568 related articles for article (PubMed ID: 19507320)
21. International Conference on Harmonisation; evaluation of stability data; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Jun; 69(110):32010-1. PubMed ID: 15185712
[TBL] [Abstract][Full Text] [Related]
22. International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(24):5551-2. PubMed ID: 14968802
[TBL] [Abstract][Full Text] [Related]
23. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
[TBL] [Abstract][Full Text] [Related]
24. International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Nov; 68(220):64628-9. PubMed ID: 14619944
[TBL] [Abstract][Full Text] [Related]
25. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
[TBL] [Abstract][Full Text] [Related]
26. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2000 Dec; 65(242):78493-4. PubMed ID: 12362934
[TBL] [Abstract][Full Text] [Related]
27. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(28):6924-5. PubMed ID: 12583358
[TBL] [Abstract][Full Text] [Related]
28. International Conference on Harmonisation; Guidance on S9 Nonclincal Evaluation for Anticancer Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Mar; 75(44):10487-8. PubMed ID: 20383918
[TBL] [Abstract][Full Text] [Related]
29. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Jan; 75(13):3471-2. PubMed ID: 20349552
[TBL] [Abstract][Full Text] [Related]
30. International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 Apr; 71(71):19193-4. PubMed ID: 16612859
[TBL] [Abstract][Full Text] [Related]
31. International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS.
Fed Regist; 1999 Aug; 64(159):44928-35. PubMed ID: 12356094
[TBL] [Abstract][Full Text] [Related]
32. International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Nov; 66(216):56332-3. PubMed ID: 12358038
[TBL] [Abstract][Full Text] [Related]
33. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
[TBL] [Abstract][Full Text] [Related]
34. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(63):16060-1. PubMed ID: 12674113
[TBL] [Abstract][Full Text] [Related]
35. International Conference on Harmonisation; guidance on the duration of chronic toxicity testing in animals (rodent and nonrodent toxicity testing); availability. Notice. Food and Drug Administration, HHS.
Fed Regist; 1999 Jun; 64(122):34259-60. PubMed ID: 12356093
[TBL] [Abstract][Full Text] [Related]
36. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
[TBL] [Abstract][Full Text] [Related]
37. International Conference on Harmonisation; guidance on the M4 Common Technical Document--Quality: Questions and Answers/Location Issues; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Jun; 69(111):32358-9. PubMed ID: 15188781
[TBL] [Abstract][Full Text] [Related]
38. International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS.
Fed Regist; 1998 Feb; 63(35):8983-6. PubMed ID: 12269370
[TBL] [Abstract][Full Text] [Related]
39. International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 May; 71(98):29344-5. PubMed ID: 16749216
[TBL] [Abstract][Full Text] [Related]
40. International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing" (VICH GL23); availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2002 Jan; 67(3):602-3. PubMed ID: 12358039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
